» Articles » PMID: 28982499

Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction

Abstract

Background: A lower heart rate is associated with better outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). Less is known about this association in patients with HF with preserved ejection fraction (HFpEF).

Objectives: The aims of this study were to examine associations of discharge heart rate with outcomes in hospitalized patients with HFpEF.

Methods: Of the 8,873 hospitalized patients with HFpEF (EF ≥50%) in the Medicare-linked OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) registry, 6,286 had a stable heart rate, defined as ≤20 beats/min variation between admission and discharge. Of these, 2,369 (38%) had a discharge heart rate of <70 beats/min. Propensity scores for discharge heart rate <70 beats/min, estimated for each of the 6,286 patients, were used to assemble a cohort of 2,031 pairs of patients with heart rate <70 versus ≥70 beats/min, balanced on 58 baseline characteristics.

Results: The 4,062 matched patients had a mean age of 79 ± 10 years, 66% were women, and 10% were African American. During 6 years (median 2.8 years) of follow-up, all-cause mortality was 65% versus 70% for matched patients with a discharge heart rate <70 versus ≥70 beats/min, respectively (hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.80 to 0.93; p < 0.001). A heart rate <70 beats/min was also associated with a lower risk for the combined endpoint of HF readmission or all-cause mortality (HR: 0.90; 95% CI: 0.84 to 0.96; p = 0.002), but not with HF readmission (HR: 0.93; 95% CI: 0.85 to 1.01) or all-cause readmission (HR: 1.01; 95% CI: 0.95 to 1.08). Similar associations were observed regardless of heart rhythm or receipt of beta-blockers.

Conclusions: Among hospitalized patients with HFpEF, a lower discharge heart rate was independently associated with a lower risk of all-cause mortality, but not readmission.

Citing Articles

Artificial intelligence approaches for phenotyping heart failure in U.S. Veterans Health Administration electronic health record.

Shao Y, Zhang S, Raman V, Patel S, Cheng Y, Parulkar A ESC Heart Fail. 2024; 11(5):3155-3166.

PMID: 38873749 PMC: 11424308. DOI: 10.1002/ehf2.14787.


Impact of heart rate changes during hospitalization on outcome in heart failure with preserved ejection fraction.

Liu D, Cui X, Xu Y, Xu L, Xie Z, Yuan S ESC Heart Fail. 2024; 11(5):2901-2912.

PMID: 38514992 PMC: 11424277. DOI: 10.1002/ehf2.14721.


Upper extremity weakness: A novel risk factor for non-cardiovascular mortality among community-dwelling older adults.

Sin M, Lee J, Murphy P, Faselis C, Ahmed A Arch Gerontol Geriatr. 2023; 112:105021.

PMID: 37058816 PMC: 10330262. DOI: 10.1016/j.archger.2023.105021.


Depressive symptoms, cognitive impairment, and all-cause mortality among REGARDS participants with heart failure.

Khodneva Y, Ringel J, Rajan M, Goyal P, Jackson E, Sterling M Eur Heart J Open. 2022; 2(5):oeac064.

PMID: 36330357 PMC: 9617474. DOI: 10.1093/ehjopen/oeac064.


Length of stay and readmission in older adults hospitalized for heart failure.

Arundel C, Lam P, Faselis C, Sheriff H, Dooley D, Morgan C Arch Med Sci. 2021; 17(4):891-899.

PMID: 34336017 PMC: 8314416. DOI: 10.5114/aoms.2019.89702.


References
1.
Beere P, Glagov S, Zarins C . Retarding effect of lowered heart rate on coronary atherosclerosis. Science. 1984; 226(4671):180-2. DOI: 10.1126/science.6484569. View

2.
Kannel W, Kannel C, Paffenbarger Jr R, Cupples L . Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987; 113(6):1489-94. DOI: 10.1016/0002-8703(87)90666-1. View

3.
Austin P . The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2013; 33(7):1242-58. PMC: 4285179. DOI: 10.1002/sim.5984. View

4.
Sheriff H, Thogaripally M, Panjrath G, Arundel C, Zeng Q, Fonarow G . Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure. J Am Med Dir Assoc. 2017; 18(9):761-765. PMC: 5677225. DOI: 10.1016/j.jamda.2017.03.016. View

5.
Zhang Y, Kilgore M, Arora T, Mujib M, Ekundayo O, Aban I . Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data. Int J Cardiol. 2011; 166(1):230-5. PMC: 3465528. DOI: 10.1016/j.ijcard.2011.10.089. View